Radionuclide and hybrid imaging of recurrent prostate cancer
- 1 February 2011
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 12 (2) , 181-191
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- A Systematic Review of the Role of Imaging before Salvage Radiotherapy for Post-prostatectomy Biochemical RecurrenceClinical Oncology, 2010
- Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical ProstatectomyJournal of Nuclear Medicine, 2009
- SPECT/CTJournal of Nuclear Medicine, 2008
- Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Choline Transporter as a Novel Target for Molecular Imaging of CancerMolecular Imaging, 2006
- [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- 11C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate CancerJournal of Clinical Oncology, 2006
- 2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical ProstatectomyClinical Cancer Research, 2005
- Positron tomographic assessment of androgen receptors in prostatic carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancersBiochemical and Biophysical Research Communications, 2002